Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |
mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |